Q1 Earnings Forecast for Innospec Issued By Seaport Res Ptn

Innospec Inc. (NASDAQ:IOSPFree Report) – Research analysts at Seaport Res Ptn lifted their Q1 2025 earnings per share (EPS) estimates for Innospec in a report released on Monday, February 24th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will earn $1.38 per share for the quarter, up from their previous estimate of $1.35. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share.

Separately, StockNews.com lowered Innospec from a “buy” rating to a “hold” rating in a research note on Wednesday.

Read Our Latest Report on Innospec

Innospec Stock Up 0.4 %

NASDAQ:IOSP opened at $104.01 on Thursday. The stock’s 50 day moving average price is $110.29 and its two-hundred day moving average price is $112.31. The firm has a market capitalization of $2.60 billion, a price-to-earnings ratio of 73.25 and a beta of 1.09. Innospec has a 12-month low of $99.49 and a 12-month high of $133.71.

Innospec (NASDAQ:IOSPGet Free Report) last released its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.05. The firm had revenue of $466.80 million for the quarter, compared to analyst estimates of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%.

Hedge Funds Weigh In On Innospec

Several institutional investors and hedge funds have recently made changes to their positions in the company. Wasatch Advisors LP grew its position in shares of Innospec by 0.6% in the third quarter. Wasatch Advisors LP now owns 1,805,546 shares of the specialty chemicals company’s stock valued at $204,189,000 after purchasing an additional 11,231 shares during the last quarter. State Street Corp grew its position in Innospec by 2.1% during the third quarter. State Street Corp now owns 996,281 shares of the specialty chemicals company’s stock worth $112,669,000 after buying an additional 20,744 shares in the last quarter. Victory Capital Management Inc. grew its position in Innospec by 1.6% during the fourth quarter. Victory Capital Management Inc. now owns 922,220 shares of the specialty chemicals company’s stock worth $101,500,000 after buying an additional 14,188 shares in the last quarter. Royce & Associates LP grew its position in Innospec by 9.3% during the third quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company’s stock worth $94,468,000 after buying an additional 70,902 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in Innospec by 2.2% during the fourth quarter. Geode Capital Management LLC now owns 692,071 shares of the specialty chemicals company’s stock worth $76,184,000 after buying an additional 14,788 shares in the last quarter. Institutional investors and hedge funds own 96.64% of the company’s stock.

Insider Buying and Selling at Innospec

In other news, SVP Corbin Barnes sold 2,692 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $103.30, for a total value of $278,083.60. Following the transaction, the senior vice president now owns 8,051 shares of the company’s stock, valued at approximately $831,668.30. This represents a 25.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Philip John Boon sold 3,754 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $387,788.20. Following the completion of the transaction, the vice president now directly owns 20,079 shares in the company, valued at $2,074,160.70. The trade was a 15.75 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,696 shares of company stock worth $794,853 over the last 90 days. Company insiders own 1.52% of the company’s stock.

About Innospec

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Recommended Stories

Earnings History and Estimates for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.